Invasive group A streptococcal infections in Florida

Clicks: 507
ID: 115407
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #2 of 4 articles by views in southern medical journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Clindamycin reduces mortality in patients with invasive GAS disease who have necrotizing fasciitis.
Reference Key
zd2003southerninvasive Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mulla ZD;Leaverton PE;Wiersma ST;;
Journal southern medical journal
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/14570340
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male middle aged risk factors Retrospective Studies anti-bacterial agents / therapeutic use hospital mortality survival rate florida / epidemiology clindamycin / therapeutic use streptococcal infections / microbiology* streptococcus pyogenes / isolation & purification* streptococcal infections / epidemiology* intensive care units / statistics & numerical data hospitalization / statistics & numerical data pmid:14570340 doi:10.1097/01.smj.0000051060.95210.9a zuber d mulla paul e leaverton steven t wiersma streptococcal infections / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.